Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection

Radiotherapy for head and neck cancers commonly causes damage to salivary gland tissue, resulting in xerostomia (dry mouth) and numerous adverse medical and quality-of-life issues. Amifostine is the only Food and Drug Administration–approved radioprotective drug used clinically to prevent xerostomia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Dent Res
Autors principals: Varghese, J.J., Schmale, I.L., Mickelsen, D., Hansen, M.E., Newlands, S.D., Benoit, D.S.W., Korshunov, V.A., Ovitt, C.E.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Research Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151913/
https://ncbi.nlm.nih.gov/pubmed/29634396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034518767408
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars